These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6335980)
1. Studies on peptides. CXXIV. Solution synthesis of the hentetracontapeptide amide corresponding to the entire amino acid sequence of human corticotropin releasing factor (hCRF). Fujii N; Nomizu M; Akaji K; Watanabe K; Shimokura M; Katakura S; Yajima H; Shono F; Tsuda M; Yoshitake A Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4797-805. PubMed ID: 6335980 [No Abstract] [Full Text] [Related]
2. Studies on peptides. CXXIII. Preparations of nine peptide fragments for the synthesis of human corticotropin releasing factor (hCRF). Fujii N; Nomizu M; Akaji K; Shimokura M; Katakura S; Yajima H Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4786-96. PubMed ID: 6335979 [No Abstract] [Full Text] [Related]
3. An optimized solid phase synthesis strategy--including on-resin lactamization--of astressin, its retro-, inverso-, and retro-inverso isomers as corticotropin releasing factor antagonists. Rijkers DT; den Hartog JA; Liskamp RM Biopolymers; 2002 Feb; 63(2):141-9. PubMed ID: 11787002 [TBL] [Abstract][Full Text] [Related]
5. Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro ACTH-releasing activity corresponding to residues 33-46 of the alpha-chain of porcine hemoglobin. Schally AV; Huang WY; Redding TW; Arimura A; Coy DH; Chihara K; Chang RC; Raymond V; Labrie F Biochem Biophys Res Commun; 1978 May; 82(2):582-8. PubMed ID: 208567 [No Abstract] [Full Text] [Related]
11. Synthesis and biological activity of N-terminal lipidated and/or fluorescently labeled conjugates of astressin as corticotropin releasing factor antagonists. Rijkers DT; den Hartog JA; Liskamp RM Bioorg Med Chem; 2004 Oct; 12(19):5099-106. PubMed ID: 15351393 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of a 37-residue peptide amide corresponding to the entire amino acid sequence of alpha-form of rat calcitonin gene-related peptide (alpha-rCGRP). Ando K; Kitagawa K; Kiyama S; Kawamoto T; Akita T; Yamamoto I; Torizuka K Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):60-71. PubMed ID: 3496172 [No Abstract] [Full Text] [Related]
13. Convulsant peptides related to corticotropin-releasing factor (CRF). Nomizu M; Miyamoto M Brain Res; 1989 Dec; 505(2):326-8. PubMed ID: 2598051 [TBL] [Abstract][Full Text] [Related]
14. Ligand requirements of the human corticotropin-releasing factor-binding protein. Sutton SW; Behan DP; Lahrichi SL; Kaiser R; Corrigan A; Lowry P; Potter E; Perrin MH; Rivier J; Vale WW Endocrinology; 1995 Mar; 136(3):1097-102. PubMed ID: 7867564 [TBL] [Abstract][Full Text] [Related]
15. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding. Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092 [TBL] [Abstract][Full Text] [Related]
16. Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides. Mazur AW; Wang F; Tscheiner M; Donnelly E; Isfort RJ J Med Chem; 2004 Jun; 47(13):3450-4. PubMed ID: 15189041 [TBL] [Abstract][Full Text] [Related]
17. Solid phase synthesis of ovine corticotropin releasing factor. Morell JL; Brown JH Int J Pept Protein Res; 1985 Jul; 26(1):49-54. PubMed ID: 3877009 [TBL] [Abstract][Full Text] [Related]